Skip to main content
Erschienen in: Supportive Care in Cancer 8/2019

04.01.2019 | Original Article

Assessing structure and characteristics of social networks among cancer survivors: impact on general health

verfasst von: Nicolette Payne, Elizabeth Palmer Kelly, Timothy M. Pawlik

Erschienen in: Supportive Care in Cancer | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Robust social networks are associated with improved health and quality of life for cancer survivors. Certain cancer diagnoses are associated with higher levels of stigma than breast cancer. However, little is known about the differences in social networks depending on the type of malignancy. This study aims to assess the differences in social networks and general health between breast cancer and more stigmatized cancers.

Methods

Cancer survivors were recruited to participate in a cross-sectional online survey study. Social network size and satisfaction was measured using the Cancer Survivor Social Networks Measure. General health was measured with a five-point-Likert-style item.

Results

The average age of the sample (n = 99) was 57.6 years old (SD = 13.4) and the majority were female (67.7%). Breast cancer survivors had an average of 1.39 more members in their social network than other cancers (t(94) = 2.28, p = 0.025). There were no significant differences between groups in network satisfaction. Results of a binary logistic regression model explained 26.9% of the variance in general health (x2(5) = 18.35, p = 0.003). There was a significant association among formal support network satisfaction (β = − 1.23, p = 0.021), formal support network size (β = − 0.36, p = 0.019), malignancy type (breast vs. other) (β = 1.05, p = 0.05), and better general health.

Conclusions

The results suggest breast cancer survivors had more formal social supports then other malignancy types. An association among greater formal social network size and satisfaction, a diagnosis of breast instead of other cancers, and better general health was noted. Emphasizing formal support sources for all cancer survivors may improve their overall health.
Literatur
4.
Zurück zum Zitat Kim BH, Wallington SF, Makambi KH, Adams-Campbell LL (2015) Social networks and physical activity behaviors among cancer survivors: data from the 2005 health information national trends survey. J Health Commun 20:656–662CrossRefPubMedPubMedCentral Kim BH, Wallington SF, Makambi KH, Adams-Campbell LL (2015) Social networks and physical activity behaviors among cancer survivors: data from the 2005 health information national trends survey. J Health Commun 20:656–662CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Fife BL, Wright ER (2000) The dimensionality of stigma: a comparison of its impact on the self of persons with HIV/AIDS and cancer. J Health Soc Behav 41:50–67CrossRefPubMed Fife BL, Wright ER (2000) The dimensionality of stigma: a comparison of its impact on the self of persons with HIV/AIDS and cancer. J Health Soc Behav 41:50–67CrossRefPubMed
8.
Zurück zum Zitat Koller M, Kussman J, Lorenz W, Jenkins M, Voss M, Arens E, Richter E, Rothmund M (1996) Symptom reporting in cancer patients: the role of negative affect and experienced social stigma. Cancer: Interdisciplinary International Journal of the American Cancer Society 77(5)983–995 Koller M, Kussman J, Lorenz W, Jenkins M, Voss M, Arens E, Richter E, Rothmund M (1996) Symptom reporting in cancer patients: the role of negative affect and experienced social stigma. Cancer: Interdisciplinary International Journal of the American Cancer Society 77(5)983–995
11.
Zurück zum Zitat Lebel S, Devins GM (2008) Stigma in cancer patients whose behavior may have contributed to their disease. Future Oncol 4(5):717–733CrossRefPubMed Lebel S, Devins GM (2008) Stigma in cancer patients whose behavior may have contributed to their disease. Future Oncol 4(5):717–733CrossRefPubMed
17.
Zurück zum Zitat ResearchMatch. Version 2018. Vanderbilt University ResearchMatch. Version 2018. Vanderbilt University
19.
Zurück zum Zitat Qualtrics Labs, Inc [computer program]. Version June 2018. Provo, Utah, USA. 2009 Qualtrics Labs, Inc [computer program]. Version June 2018. Provo, Utah, USA. 2009
20.
Zurück zum Zitat IBM Corp. Released 2017. IBM SPSS statistics for Macintosh, version 25.0. IBM Corp, Armonk IBM Corp. Released 2017. IBM SPSS statistics for Macintosh, version 25.0. IBM Corp, Armonk
26.
Zurück zum Zitat Kuchler T, Henne-Bruns D, Rappat S et al (1999) Impact of psychotherapeutic support on gastrointestinal cancer patients undergoing surgery: survival results of a trial. Hepatogastroenterology 46(25):322–335PubMed Kuchler T, Henne-Bruns D, Rappat S et al (1999) Impact of psychotherapeutic support on gastrointestinal cancer patients undergoing surgery: survival results of a trial. Hepatogastroenterology 46(25):322–335PubMed
31.
Zurück zum Zitat Zhu K, Hunter S, Bernard LJ et al (2000) Mammography screening in single older African-American women: a study of related factors. Ethn Dis Zhu K, Hunter S, Bernard LJ et al (2000) Mammography screening in single older African-American women: a study of related factors. Ethn Dis
32.
Zurück zum Zitat Kang SH, Bloom JR (1993) Social support and cancer screening among older black Americans. J Natl Cancer Inst 85:737–742CrossRefPubMed Kang SH, Bloom JR (1993) Social support and cancer screening among older black Americans. J Natl Cancer Inst 85:737–742CrossRefPubMed
40.
Zurück zum Zitat Guidry JJ, Aday LA, Zhang D, Winn RJ (1997) The role of informal and formal social support networks for patients with cancer. Cancer Pract Guidry JJ, Aday LA, Zhang D, Winn RJ (1997) The role of informal and formal social support networks for patients with cancer. Cancer Pract
43.
Zurück zum Zitat Decker CL (2007) Social support and adolescent cancer survivors: a review of the literature. Psychooncology 16:1–11CrossRefPubMed Decker CL (2007) Social support and adolescent cancer survivors: a review of the literature. Psychooncology 16:1–11CrossRefPubMed
Metadaten
Titel
Assessing structure and characteristics of social networks among cancer survivors: impact on general health
verfasst von
Nicolette Payne
Elizabeth Palmer Kelly
Timothy M. Pawlik
Publikationsdatum
04.01.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 8/2019
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4620-4

Weitere Artikel der Ausgabe 8/2019

Supportive Care in Cancer 8/2019 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.